XML 28 R17.htm IDEA: XBRL DOCUMENT
v3.24.3

Earnings/(Net Loss) Per Share Attributable to Common Stockholders | 3 Months Ended
--- | ---
Mar. 31, 2024
Earnings Per Share [Abstract] |
Earnings/(Net Loss) Per Share Attributable to Common Stockholders | 11. Earnings/(Net Loss) Per Share Attributable to Common Stockholders The following table presents the calculation of basic and diluted earnings/(net loss) per share attributable to holders of Common Stock (in thousands, except share and per share amounts): Schedule of Basic and Diluted Net Loss Per Share
|  | 2024 |  |  | 2023 |
|  | For the three months ended March 31, |
|  | 2024 |  |  | 2023 |
Numerator: |  |  |  |  |  |
Net loss - basic |  | $ | (3,571 | ) |  | $ | (1,672 | )
Less: Change in fair value and income impact of Cizzle option liability |  |  | - |  |  |  | (136 | )
Net loss - diluted |  | $ | (3,571 | ) |  | $ | (1,808 | )
Denominator: |  |  |  |  |  |  |  |
Weighted average common stock outstanding, basic |  |  | 73,829,536 |  |  |  | 64,626,430 |
Add: Cizzle option liability shares |  |  | - |  |  |  | 395,460 |
Weighted average shares used in computing net loss per share - diluted |  |  | 73,829,536 |  |  |  | 65,021,890 |
Net loss per share attributable to common shareholders, basic |  | $ | (0.05 | ) |  | $ | (0.03 | )
Net income loss per share attributable to common shareholders, diluted |  | $ | (0.05 | ) |  | $ | (0.03 | )
Potentially dilutive securities (upon conversion) that were not included in the diluted per share calculations because they would have been anti-dilutive were as follows: Schedule of Potentially Dilutive Securities
|  | As of March 31, |  |  | As of March 31, |
|  | 2024 |  |  | 2023 |
Equity classified warrants |  |  | 14,239,000 |  |  |  | - |
Liability classified warrants |  |  | 20,054,000 |  |  |  | - |
Convertible notes payable |  |  | - |  |  |  | 3,070,000 |
Stock options |  |  | 1,071,719 |  |  |  | - |
Convertible promissory notes payable |  |  | 80,500 |  |  |  | - |
Restricted stock units |  |  | 146,963 |  |  |  | - |
Antidilutive Securities |  |  | 35,592,182 |  |  |  | 3,070,000 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration